This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lass, N. A. Articles by Goldberg, L. I. Search for Related Content PubMed PubMed Citation Articles by Lass, N. A. Articles by Goldberg, L. I.

Circulation, Vol 78, 1310-1315, Copyright © 1988 by American Heart Association

ARTICLES

Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine

NA Lass, D Glock and LI Goldberg
Department of Pharmacological and Physiological Sciences, University of Chicago, Illinois 60637.

Fenoldopam (0.1 and 0.2 microgram/kg/min i.v.) was administered to pentobarbital-anesthetized dogs alone and combined with dopamine (DA) and dobutamine. Renal blood flow, heart rate, and mean arterial pressure were measured. Both dosages of fenoldopam increased renal blood flow without altering blood pressure, similar to the effects of DA (1 and 2 micrograms/kg/min). Administration of fenoldopam with only DA (1 microgram/kg/min) produced further increase in renal blood flow. After administration of phenoxybenzamine (15 mg/kg i.v.), DA produced significant increments in renal blood flow and reductions in renal vascular resistance when compared with experiments without phenoxybenzamine, suggesting even low dosages of DA exert alpha- adrenoceptor agonist activity. Dobutamine (2 and 4 micrograms/kg/min) increased renal blood flow about 37% of that produced by DA. Fenoldopam added to dobutamine produced similar increments in renal blood flow as DA. Fenoldopam did not affect the increase in cardiac contractile force produced by DA and dobutamine. Thus, fenoldopam alone or in combination with DA had no advantage over 2 and 4 micrograms/kg/min DA to further increase renal blood flow. In contrast, fenoldopam with dobutamine produced greater increments in cardiac contractile force than DA and equivalent increases in renal blood flow as DA.

This article has been cited by other articles:

				A. A. Chamsuddin, K. J. Kowalik, H. Bjarnason, C. A. Dietz, M. S. Rosenberg, M. D. Gomes, C. M. McDermott, and D. W. Hunter Using a Dopamine Type IA Receptor Agonist in High-Risk Patients to Ameliorate Contrast-Associated Nephropathy Am. J. Roentgenol., September 1, 2002; 179(3): 591 - 596. [Abstract] [Full Text] [PDF]

				K. Wei, E. Le, J.-P. Bin, M. Coggins, J. Thorpe, and S. Kaul Quantification of renal blood flow with contrast-enhanced ultrasound J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1135 - 1140. [Abstract] [Full Text] [PDF]

				F. Pea, L. Porreca, M. Baraldo, and M. Furlanut High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures J. Antimicrob. Chemother., March 1, 2000; 45(3): 329 - 335. [Abstract] [Full Text] [PDF]